Lonny Yarmus
Experienced in Squamous Cell Lung Carcinoma

Dr. Lonny Yarmus

Pulmonary Medicine
Johns Hopkins Medicine
The Johns Hopkins Hospital
Baltimore, MD 
Experienced in Squamous Cell Lung Carcinoma
Johns Hopkins Medicine
The Johns Hopkins Hospital
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Yarmus is a Professor of Medicine and Oncology and the director of Interventional Pulmonology at the Johns Hopkins University School of Medicine as well as the Vice Chair of Medicine for Strategy and Finance. He is an expert in the minimally invasive diagnosis and treatment of lung cancer and he leads the Interventional Pulmonary research program at Johns Hopkins with research investigating innovative minimally invasive device development and early-stage bronchoscopic treatments. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management, pleural diseases and symptom relief with minimally invasive procedures such as indwelling pleural catheters and pleurodesis. Dr. Yarmus is a member of the Fleischner Society and a fellow of the American College of Chest Physicians and the American Thoracic Society.

Dr. Yarmus is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy.

His clinical research consists of co-authoring 242 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Johns Hopkins Carey Business School, MBA, 2018
Residency
Maine Medical Center, Pulmonary and Critical Care Medicine, 2006
Specialties
Pulmonary Medicine
Licenses
Critical Care Medicine in NY
Fellowships
Johns Hopkins University School of Medicine, Pulmonary Medicine, 2009
Maine Medical Center, Pulmonary and Critical Care Medicine, 2009
Hospital Affiliations
The Johns Hopkins Hospital
Johns Hopkins Bayview Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

The Johns Hopkins Hospital
Baltimore, MD 21287
Call: 410-955-5000
Other Locations
Johns Hopkins Bayview Medical Center
4940 Eastern Avenue, Baltimore, MD 21224
Call: 410-550-0100

Additional Areas of Focus

Dr. Yarmus has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Lung Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules
A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Randomized, Placebo-controlled, Double-blind, Dose-ranging Study Evaluating LTI-01 (Single-chain Urokinase Plasminogen Activator, scuPA) in Patients With Infected, Non-draining Pleural Effusions
A Phase 2, Randomized, Placebo-controlled, Double-blind, Dose-ranging Study Evaluating LTI-01 (Single-chain Urokinase Plasminogen Activator, scuPA) in Patients With Infected, Non-draining Pleural Effusions
Enrollment Status: Completed
Publish Date: March 30, 2023
Intervention Type: Drug
Study Drug: LTI-01
Study Phase: Phase 2
Safety of a Sheath Cryoprobe Bronchoscopic Transbronchial Biopsy Technique (The FROSTBITE Trial)
Safety of a Sheath Cryoprobe Bronchoscopic Transbronchial Biopsy Technique (The FROSTBITE Trial)
Enrollment Status: Completed
Publish Date: February 25, 2022
Intervention Type: Device
Study Phase: Not Applicable
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Enrollment Status: Completed
Publish Date: February 15, 2021
Intervention Type: Other
NanoSpectrometer Biomarker Discovery and Confirmation Study
NanoSpectrometer Biomarker Discovery and Confirmation Study
Enrollment Status: Terminated
Publish Date: July 22, 2020
Intervention Type: Diagnostic test
Multicenter, Prospective, Randomized Trial of Bronchoscopy With Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) With Fluoroscopy for Biopsy of Pulmonary Lesions
Multicenter, Prospective, Randomized Trial of Bronchoscopy With Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) With Fluoroscopy for Biopsy of Pulmonary Lesions
Enrollment Status: Completed
Publish Date: September 25, 2018
Intervention Type: Device
Study Phase: Not Applicable
A Multi-center Study Comparing Standard 22-gauge and 22-gauge ProCore Needles for Endobronchial Ultrasound
A Multi-center Study Comparing Standard 22-gauge and 22-gauge ProCore Needles for Endobronchial Ultrasound
Enrollment Status: Completed
Publish Date: April 30, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 8 Less Clinical Trials

242 Total Publications

Robotic versus electromagnetic bronchoscopy for pulmonary leslon assessment using integrated intraprocedural imaging: Study protocol for the reliant 2 trial.
Robotic versus electromagnetic bronchoscopy for pulmonary leslon assessment using integrated intraprocedural imaging: Study protocol for the reliant 2 trial.
Journal: PloS one
Published: July 02, 2025
View All 242 Publications
Similar Doctors
Distinguished in Squamous Cell Lung Carcinoma
Dr. Eric D. Anderson
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Squamous Cell Lung Carcinoma
Dr. Eric D. Anderson
Pulmonary Medicine | Intensive Care Medicine

Medstar Medical Group Ii LLC

3800 Reservoir Rd Nw, 
Washington, DC 
 (37.1 miles away)
202-444-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eric Anderson is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Washington, Washington, D.c.. Dr. Anderson is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Large-Cell Lung Carcinoma, Squamous Cell Lung Carcinoma, and Advanced Bronchoscopy.

Distinguished in Squamous Cell Lung Carcinoma
Dr. Rebecca L. Krochmal
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Squamous Cell Lung Carcinoma
Dr. Rebecca L. Krochmal
Pulmonary Medicine | Intensive Care Medicine

Medstar Medical Group Ii LLC

1145 19th St Nw, 311 Mmg At 19th Street Nw, 
Washington, DC 
 (36.3 miles away)
202-429-2401
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rebecca Krochmal is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Washington, Washington, D.c.. Dr. Krochmal is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, Endoscopy, and Gastrostomy. Dr. Krochmal is currently accepting new patients.

Distinguished in Squamous Cell Lung Carcinoma
Dr. Amit Mahajan
Pulmonary Medicine
Distinguished in Squamous Cell Lung Carcinoma
Dr. Amit Mahajan
Pulmonary Medicine

Inova Schar Cancer-White Oak Clinic (Dept Of Fairfax Hospital)

8081 Innovation Park Dr Fl 4, 
Fairfax, VA 
 (46.9 miles away)
571-472-1380
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Amit Mahajan is a Pulmonary Medicine provider in Fairfax, Virginia. Dr. Mahajan is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Nodules, Lymphofollicular Hyperplasia, Lung Cancer, Endoscopy, and Advanced Bronchoscopy.

VIEW MORE SQUAMOUS CELL LUNG CARCINOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yarmus's expertise for a condition
ConditionClose
  • Elite
  • Pleural Effusion
    Dr. Yarmus is
    Elite
    . Learn about Pleural Effusion.
    See more Pleural Effusion experts
  • Distinguished
  • Advanced Bronchoscopy
    Dr. Yarmus is
    Distinguished
    . Learn about Advanced Bronchoscopy.
    See more Advanced Bronchoscopy experts
  • Endoscopy
    Dr. Yarmus is
    Distinguished
    . Learn about Endoscopy.
    See more Endoscopy experts
  • Lung Cancer
    Dr. Yarmus is
    Distinguished
    . Learn about Lung Cancer.
    See more Lung Cancer experts
  • Lung Nodules
    Dr. Yarmus is
    Distinguished
    . Learn about Lung Nodules.
    See more Lung Nodules experts
  • Lymphofollicular Hyperplasia
    Dr. Yarmus is
    Distinguished
    . Learn about Lymphofollicular Hyperplasia.
    See more Lymphofollicular Hyperplasia experts
  • Advanced
  • Empyema
    Dr. Yarmus is
    Advanced
    . Learn about Empyema.
    See more Empyema experts
  • Gastrostomy
    Dr. Yarmus is
    Advanced
    . Learn about Gastrostomy.
    See more Gastrostomy experts
  • Non-Small Cell Lung Cancer (NSCLC)
    Dr. Yarmus is
    Advanced
    . Learn about Non-Small Cell Lung Cancer (NSCLC).
    See more Non-Small Cell Lung Cancer (NSCLC) experts
  • Tracheobronchomalacia
    Dr. Yarmus is
    Advanced
    . Learn about Tracheobronchomalacia.
    See more Tracheobronchomalacia experts
  • Experienced
  • Acquired Tracheomalacia
    Dr. Yarmus is
    Experienced
    . Learn about Acquired Tracheomalacia.
    See more Acquired Tracheomalacia experts
  • Acute Interstitial Pneumonia
    Dr. Yarmus is
    Experienced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Yarmus is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Asthma
    Dr. Yarmus is
    Experienced
    . Learn about Asthma.
    See more Asthma experts
  • Atypical Pneumonia
    Dr. Yarmus is
    Experienced
    . Learn about Atypical Pneumonia.
    See more Atypical Pneumonia experts
  • Bronchiectasis
    Dr. Yarmus is
    Experienced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
View All 26 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.